Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.Health effect - clinical code: e0717.Health effect - clinical code: e210401.Health effect - clinical code: e1009.
|
It was reported that patient has experienced painful stimulation in the throat, muscle spasms of the neck, paresis of right and leftvocal cords ,dyspnea, and dysphagia.The events are directly associated with device stimulation per the physician and he suspects an abrasion in the lead insulation is the cause, providing stimulation to unintended sites even though system diagnostics are within normal limits and no lead discontinuities were seen in ct scan.The patient has been referred for a lead revision.No known relevant surgical intervention has occurred to date.No other relevant information has been received to date.
|